Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1–36
Headlines
57
Sources here
14
Companies here
3
Current section United States Pharmaceutical Retailers news
Latest

seekingalpha.com Earnings

PetMed Express GAAP EPS of -$0.28 misses by $0.40, revenue of $41.02M

* PetMed Express press release [https://seekingalpha.com/pr/20619131-petmeds-announces-first-quarter-financial-results] (PETS [https://seekingalpha.com/symbol/PETS]): Q1 GAAP EPS of -$0.28 misses by $0.40. * Revenue of $41.02M (-19.9% Y/Y). MORE ON PETMED EXPRESS * PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript [https://seekingalpha.com/article/4911174-petmed-express-inc-pets-q4-2026-earnings-call-prepared-remarks-transcript] * PetMed Express: High-Risk Turnaround, Hidden Assets, Activism [https://seekingalpha.com/article/4909320-petmed-express-high-risk-turnarou

Main company 🇺🇸 United States
Read at seekingalpha.com
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Just inNext headlines
Stock Titan Market update Main company 🇺🇸 United States

PetMed Express (PETS) grants director Peter Batushansky 55,555 restricted shares

PetMed Express (PETS) director Peter Batushansky was granted 55,555 restricted shares of common stock under the company's 2024 Omnibus Incentive Plan. These shares will fully vest on August 11, 2027, provided he continues his service on the Board of Directors, bringing his total direct …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

PetMed Express (PETS) awards 55,555-share restricted stock grant to director Mennen

PetMed Express (PETS) has awarded director Justin L. Mennen a restricted stock grant of 55,555 shares of common stock under the company's 2024 Omnibus Incentive Plan. These shares will fully vest on August 11, 2027, provided Mennen continues his service on the Board of …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Chronological news

Latest headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Stock Titan Earnings Main company 🇺🇸 United States

Scienture Begins Nationwide Distribution of 10 mg Opioid-Overdose Spray

Scienture (NASDAQ: SCNX) has commercially launched REZENOPY™ (naloxone hydrochloride) Nasal Spray 10 mg, fulfilling initial U.S. wholesaler purchase orders for its second FDA-approved commercial product. This highest-dose naloxone nasal spray is now being distributed nationwide for emergency treatment of opioid overdose, supported by a …

SCNX main company
Sharemaestro market context Price below Trend Line 52 weeks -68.6% · Next-week setup negative 39.3% SCNX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

PetMed Express, Inc. expected to post earnings of 12 cents a share - Earnings Preview

PetMed Express, Inc. is projected to report earnings of 12 cents per share. This information is presented as an earnings preview from Reuters, indicating an upcoming financial announcement for the company.

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Finimize Deals and strategy Main company 🇺🇸 United States

PetMed Express Trades Like A Bargain, But Losses Persist

PetMed Express (NASDAQ: PETS), an online pet pharmacy, is experiencing significant losses and declining sales, leading to its stock trading at a deep discount of around $1.96 per share. Despite the low valuation and a recent unsolicited acquisition proposal of $3.00 per share, the …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Yahoo! Finance Canada Earnings Main company 🇺🇸 United States

PetMed Express, Inc. (PETS) Stock Price, News, Quote & History

This Yahoo Finance page provides a comprehensive overview of PetMed Express, Inc. (PETS) stock, including its current price, historical data, financial performance, and analyst insights. The company operates as a pet pharmacy in the United States, offering a range of prescription and non-prescription pet …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

DataMeds AI, Inc. (Nasdaq: MEDS) details 34,462,058-share resale

DataMeds AI, Inc. (Nasdaq: MEDS) has filed an S-1 registration statement detailing the resale of up to 34,462,058 shares of common stock by existing selling stockholders. These shares originate from previously issued stock, convertible notes from May 2026, and various warrants. The company itself …

WGRX main company
Sharemaestro market context Price below Trend Line 51 weeks -93.7% · Next-week setup negative 29.0% WGRX stored weekly price path from 1 Aug 2025 to 17 Jul 2026
TradingKey Market update Main company 🇺🇸 United States

Scienture Holdings Inc (SCNX) Stock News Today

This article provides an overview of Scienture Holdings Inc. (SCNX) stock information, including its current trading price, market cap, and a note about upcoming news. It indicates that more news regarding the company's stock, earnings, and analyst ratings will be available soon.

SCNX main company
Sharemaestro market context Price below Trend Line 52 weeks -68.6% · Next-week setup negative 39.3% SCNX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Scienture Holdings Inc (SCNX) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Scienture Holdings Inc (SCNX), indicating a current earnings forecast score of 8.00 and a "Buy" trend based on one analyst's rating with a target price reflecting a 302.47% upside. It details expected revenue for the next quarter …

SCNX main company
Sharemaestro market context Price below Trend Line 52 weeks -68.6% · Next-week setup negative 39.3% SCNX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Petmed Express Inc (PETS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Petmed Express Inc (PETS), detailing its current earnings forecast score, average price target, and analyst rating. It highlights that the company ranks 19th out of 29 in its industry with a "Sell" rating from one analyst, and …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

PETS Q1'26 Earnings: revenue estimate is 71.00M USD

PetMed Express, Inc. (PETS) is expected to release its Q1'26 earnings on August 13, after market close, with an estimated revenue of $71.00 million and EPS of $0.12. The article provides a detailed table comparing historical reported and estimated revenue and EPS figures from …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Deals and strategy Main company 🇺🇸 United States

DataMEDS AI (WGRX) LOI could give new partners 84.6% ownership stake

DataMEDS AI, Inc. (WGRX) has entered into an Amended and Restated Letter of Intent with several partners to negotiate a stock-based transaction. This potential deal involves acquiring or licensing intellectual property, expanding existing licenses, and obtaining a controlling interest in Tollo Health, LLC. If …

WGRX main company
Sharemaestro market context Price below Trend Line 51 weeks -93.7% · Next-week setup negative 29.0% WGRX stored weekly price path from 1 Aug 2025 to 17 Jul 2026
Kalkine Earnings Main company 🇺🇸 United States

PetMed Express Inc (NASDAQ: PETS) Share Price, PETS Stock News, PETS Share Price & Updates

This article provides detailed financial data and company information for PetMed Express Inc (NASDAQ: PETS), including its stock performance, fundamentals, and recent financial results. It highlights a partnership with Dutch for accessible telehealth services for pets and offers a comprehensive overview of the company's …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
The Manila Times Earnings Main company 🇺🇸 United States

PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026

PetMed Express, Inc. (Nasdaq: PETS) announced that it will report its financial results for the first quarter of fiscal year 2027, which ended June 30, 2026, on Thursday, August 13, 2026, after the market closes. The company will also host a conference call and …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Pluang Earnings Main company 🇺🇸 United States

PetMed Express to announce Q1 FY2027 results on August 13 after market close

PetMed Express will report its first-quarter fiscal year 2027 financial results on August 13, 2026, after the market closes. The online pet pharmacy will host a conference call and webcast at 4:30 PM Eastern Time to discuss these results. A replay of the call …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

PetMeds sets 4:30 p.m. webcast to review first-quarter results

PetMed Express (NASDAQ: PETS) announced it will release its financial results for the first quarter of fiscal year 2027, covering the period ended June 30, 2026,

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

SCNX|Scienture Holdings Inc|Price:0.355|Chg%:-0.020

This article provides a detailed stock analysis of Scienture Holdings Inc (SCNX), highlighting its healthy fundamentals, significant growth potential, and fair valuation within the Pharmaceuticals industry. The company, focused on developing treatments for central nervous system and cardiovascular diseases, is currently in a growing …

SCNX main company
Sharemaestro market context Price below Trend Line 52 weeks -68.6% · Next-week setup negative 39.3% SCNX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Petmed Express Inc (PETS) Institutional Confidence

This article analyzes the institutional confidence in Petmed Express Inc (PETS), showing its current institutional shareholding score and ranking within the Food & Drug Retailing industry. It details the latest institutional shareholding proportion, the largest institutional shareholder (James Simons), and a list of key …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Scienture Holdings Inc (SCNX) Financial Health: Profitability & Balance Sheet Analysis

Scienture Holdings Inc (SCNX) currently holds a financial score of 6.05, placing it 145th out of 155 in the Pharmaceuticals industry, indicating robust financial health but low operating efficiency. The company recently reported a significant year-over-year revenue increase of 449.08% to 56.33K and an …

SCNX main company
Sharemaestro market context Price below Trend Line 52 weeks -68.6% · Next-week setup negative 39.3% SCNX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Scienture Holdings Inc (SCNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Scienture Holdings Inc (SCNX), detailing its stock price momentum, support and resistance levels, and various technical indicators and moving averages. As of July 29, 2026, SCNX has a price momentum score of 5.32, with the stock trading …

SCNX main company
Sharemaestro market context Price below Trend Line 52 weeks -68.6% · Next-week setup negative 39.3% SCNX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

PetMed Express, Inc. Revenue Breakdown – LSX:121843

PetMed Express, Inc. (LSX:121843) generated €154.95 million in revenue last year, with its Reorder segment contributing the most at €127.91 million. The United States was the primary regional contributor, accounting for all reported revenue. This indicates a focus on the U.S. market and recurring …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Webull Earnings Main company 🇺🇸 United States

When Will Scienture Holdings, Inc. (NASDAQ:SCNX) Become Profitable?

Scienture Holdings, Inc. (NASDAQ:SCNX) is a pharmaceutical company that has expanded its losses, reporting a US$42m loss recently. Analysts predict the company could reach profitability by 2028, with an expected profit of US$9.0m, requiring an aggressive average annual growth rate of 71%. The company …

SCNX main company
Sharemaestro market context Price below Trend Line 52 weeks -68.6% · Next-week setup negative 39.3% SCNX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Scienture Holdings Inc (SCNX) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Scienture Holdings Inc (SCNX), highlighting its volatility and financial risks. SCNX has a beta value of 3.25, indicating high sensitivity to market movements, and a low risk assessment score within the Pharmaceuticals industry. The report details various …

SCNX main company
Sharemaestro market context Price below Trend Line 52 weeks -68.6% · Next-week setup negative 39.3% SCNX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Democrat and Chronicle Earnings Main company 🇺🇸 United States

Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy

Wellgistics Health Inc. (NASDAQ:WGRX) has announced the termination of its equity purchase agreement with Hudson Global Ventures, LLC, a strategic move to shift towards accretive financing and reinforce long-term shareholder value. The decision was driven by strong execution in expanding its pharmacy network and …

WGRX main company
Sharemaestro market context Price below Trend Line 51 weeks -93.7% · Next-week setup negative 29.0% WGRX stored weekly price path from 1 Aug 2025 to 17 Jul 2026
TradingView Earnings Main company 🇺🇸 United States

Scienture Holdings, Inc. Revenue Breakdown – NASDAQ:SCNX

Scienture Holdings, Inc. (NASDAQ:SCNX) generated $431.61K USD in revenue last year, primarily from its Products for the Treatment of Cardiovascular and Central Nervous System Diseases segment. The United States was the leading contributor, accounting for the entire $431.61K USD in revenue, an increase from …

SCNX main company
Sharemaestro market context Price below Trend Line 52 weeks -68.6% · Next-week setup negative 39.3% SCNX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Scienture Holdings Inc (SCNX) Cash Flow

This article provides the quarterly and annual cash flow statements for Scienture Holdings Inc (SCNX), allowing users to assess the company's financial health. It details operating, investing, and financing cash flows, along with related metrics like net income from continuing operations and free cash …

SCNX main company
Sharemaestro market context Price below Trend Line 52 weeks -68.6% · Next-week setup negative 39.3% SCNX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Petmed Express Inc (PETS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of Petmed Express Inc (PETS) dividends and stock splits. It details cash dividend payouts from May 2021 to August 2023, specifying the dividend amount, record date, payment date, and ex-dividend date for each. The data indicates that PETS …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Petmed Express Inc (PETS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Petmed Express Inc (PETS), focusing on its business segments. Key revenue contributions for FY2026Q3 show that reorder sales account for the vast majority (83.67%) of revenue, followed by new order sales (12.37%), and membership fees (3.96%). Regional …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingKey Deals and strategy Main company 🇺🇸 United States

Scienture Holdings Inc (SCNX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of dividend payouts and stock splits for Scienture Holdings Inc (SCNX). It notes that the company has distributed $0.00 in dividends over the past five years and details multiple 15-to-1 merger-related stock splits on June 21, 2023. The …

SCNX main company
Sharemaestro market context Price below Trend Line 52 weeks -68.6% · Next-week setup negative 39.3% SCNX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Moomoo Market update Main company 🇺🇸 United States

WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.

Wellgistics Health, Inc. has officially changed its corporate name to DataMeds AI, Inc. This rebranding reflects the company's strategic shift towards integrating artificial intelligence and advanced data analytics into its healthcare solutions. The new name emphasizes its commitment to leveraging technology for innovative medical …

WGRX main company
Sharemaestro market context Price below Trend Line 51 weeks -93.7% · Next-week setup negative 29.0% WGRX stored weekly price path from 1 Aug 2025 to 17 Jul 2026
TradingKey Earnings Main company 🇺🇸 United States

PETS|Petmed Express Inc|Price:1.990|Chg%:-0.060

Petmed Express Inc (PETS) closed at $1.99, down 2.93% on July 24, 2026. The company, a direct-to-consumer pet pharmacy, shows strong fundamentals and high growth potential but is considered fairly valued with analysts rating it as "Sell." Its stock price is expected to trend …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

SCNX|Scienture Holdings Inc|Price:0.374|Chg%:-0.017

Scienture Holdings Inc. (SCNX) is a specialty pharmaceutical company focused on developing products for central nervous system and cardiovascular diseases. The company is developing several product candidates, including treatments for hypertension, migraine, pain, and thrombosis. Key executives and institutional shareholding information are also provided, …

SCNX main company
Sharemaestro market context Price below Trend Line 52 weeks -68.6% · Next-week setup negative 39.3% SCNX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

PetMed Express (NASDAQ: PETS) awards stock and PSUs to interim CFO

PetMed Express (NASDAQ: PETS) has awarded interim CFO Douglas Krulik 32,500 restricted common shares and 32,500 performance share units (PSUs). The restricted shares vest 50% on June 26, 2027, and 50% on June 26, 2028, contingent on continued employment. The PSUs are tied to …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
www.marketscreener.com Market update Main company 🇺🇸 United States

Wellgistics Health Selects Top Five Blockchain Platforms to Initiate Patent Protected PharmacyChain(TM) Smart Contracts-enabled Pharmaceutical Drug Tracking System to Support Industry-wide Serialization Mandate

Wellgistics Health, Inc. has chosen Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum/Besu, and Corda (R3) as the top five blockchain platforms to develop its patent-protected PharmacyChain™ system. This system will utilize smart contracts to track pharmaceutical drugs, supporting industry-wide serialization mandates like the DSCSA. The company …

WGRX main company
Sharemaestro market context Price below Trend Line 51 weeks -93.7% · Next-week setup negative 29.0% WGRX stored weekly price path from 1 Aug 2025 to 17 Jul 2026
Market source Analyst action Main company 🇺🇸 United States

PetMed Express, Inc. (PETS) stock price, news, quote and history

PetMed Express, Inc. (PETS) stock closed at $1.99, down 2.93% on July 24, 2026, with an after-hours price of $1.9013. The company, a pet pharmacy providing prescription and non-prescription medications and supplies, has seen significant negative returns over the past year and five years, …

PETS main company
Sharemaestro market context Price below Trend Line 52 weeks -33.1% · Next-week setup negative 42.6% PETS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context